116 related articles for article (PubMed ID: 12605606)
21. Conformational dynamics of human alpha-fetoprotein-derived heptapeptide LDSYQCT analogs.
Moldogazieva NT; Terentiev AA; Kazimirsky AN; Antonov MY; Shaitan KV
Biochemistry (Mosc); 2007 May; 72(5):529-39. PubMed ID: 17573707
[TBL] [Abstract][Full Text] [Related]
22. Structure and function of the Zn(II) binding site within the DNA-binding domain of the GAL4 transcription factor.
Pan T; Coleman JE
Proc Natl Acad Sci U S A; 1989 May; 86(9):3145-9. PubMed ID: 2497463
[TBL] [Abstract][Full Text] [Related]
23. Zn
Garapati S; Monteith W; Wilson C; Kostenko A; Kenney JM; Danell AS; Burns CS
J Biol Inorg Chem; 2018 Dec; 23(8):1255-1263. PubMed ID: 30187212
[TBL] [Abstract][Full Text] [Related]
24. Examining the zinc binding site of the amyloid-beta peptide.
Yang DS; McLaurin J; Qin K; Westaway D; Fraser PE
Eur J Biochem; 2000 Nov; 267(22):6692-8. PubMed ID: 11054124
[TBL] [Abstract][Full Text] [Related]
25. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
[TBL] [Abstract][Full Text] [Related]
26. The DNA binding domain of GAL4 forms a binuclear metal ion complex.
Pan T; Coleman JE
Biochemistry; 1990 Mar; 29(12):2023-9. PubMed ID: 2186803
[TBL] [Abstract][Full Text] [Related]
27. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
28. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
29. N-terminal fragment of the anti-angiogenic human endostatin binds copper(II) with very high affinity.
Kolozsi A; Jancsó A; Nagy NV; Gajda T
J Inorg Biochem; 2009 Jul; 103(7):940-7. PubMed ID: 19447499
[TBL] [Abstract][Full Text] [Related]
30. Metal ion affinities of the zinc finger domains of the metal responsive element-binding transcription factor-1 (MTF1).
Guerrerio AL; Berg JM
Biochemistry; 2004 May; 43(18):5437-44. PubMed ID: 15122909
[TBL] [Abstract][Full Text] [Related]
31. Zn(2+) ions selectively induce antimicrobial salivary peptide histatin-5 to fuse negatively charged vesicles. Identification and characterization of a zinc-binding motif present in the functional domain.
Melino S; Rufini S; Sette M; Morero R; Grottesi A; Paci M; Petruzzelli R
Biochemistry; 1999 Jul; 38(30):9626-33. PubMed ID: 10423240
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
[TBL] [Abstract][Full Text] [Related]
33. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
34. Zn(II) binding and DNA binding properties of ligand-substituted CXHH-type zinc finger proteins.
Imanishi M; Matsumura K; Tsuji S; Nakaya T; Negi S; Futaki S; Sugiura Y
Biochemistry; 2012 Apr; 51(16):3342-8. PubMed ID: 22482427
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.
Mizejewski GJ; Mirowski M; Garnuszek P; Maurin M; Cohen BD; Poiesz BJ; Posypanova GA; Makarov VA; Severin ES; Severin SE
J Drug Target; 2010 Sep; 18(8):575-88. PubMed ID: 20151941
[TBL] [Abstract][Full Text] [Related]
36. Structure-function relationships of the NMDA receptor antagonist peptide, conantokin-R.
Blandl T; Warder SE; Prorok M; Castellino FJ
FEBS Lett; 2000 Mar; 470(2):139-46. PubMed ID: 10734223
[TBL] [Abstract][Full Text] [Related]
37. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion.
Angeletti RH; Mints L; Aber C; Russell J
Endocrinology; 1996 Jul; 137(7):2918-22. PubMed ID: 8770914
[TBL] [Abstract][Full Text] [Related]
38. Human nucleotide excision repair protein XPA: 1H NMR and CD solution studies of a synthetic peptide fragment corresponding to the zinc-binding domain (101-141).
Buchko GW; Kennedy MA
J Biomol Struct Dyn; 1997 Jun; 14(6):677-90. PubMed ID: 9195337
[TBL] [Abstract][Full Text] [Related]
39. Enhanced protein thermostability by Ala-->Aib replacement.
De Filippis V; De Antoni F; Frigo M; Polverino de Laureto P; Fontana A
Biochemistry; 1998 Feb; 37(6):1686-96. PubMed ID: 9484240
[TBL] [Abstract][Full Text] [Related]
40. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
